This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (158)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Daniel M. Huse, MA; Gerry Oster, PhD; Alice R. Killen, MBBS, MPH; Michael J. Lacey; Graham A. Colditz, MBBS, DrPH

JAMA. 1989;262(19):2708-2713.

Abstract
Persons with diabetes experience elevated risks of a variety of other illnesses— including circulatory, visual, neurological, renal, and skin disorders—relative to their nondiabetic peers. Previous estimates of the economic burden of diabetes, however, have not taken full account of this related morbidity and mortality and have therefore understated the cost to the nation due to this disease. Accordingly, we estimated the economic costs of type II, or non-insulin-dependent, diabetes mellitus, reflecting its contribution to the total burden of disease in the United States. In 1986, non—insulin-dependent diabetes mellitus was responsible for $11.6 billion in health care expenditures, including $6.8 billion for diabetic care and $4.8 billion attributable to an excess prevalence of related (principally cardiovascular) conditions. The human toll of non—insulin-dependent diabetes mellitus included 144 000 deaths—about 6.8% of total US mortality—and the total disability of 951 000 persons. The total economic burden of non—insulin-dependent diabetes mellitus in 1986, including health care expenditures and productivity forgone due to disability and premature mortality, was $19.8 billion.

(JAMA. 1989;262:2708-2713)

Author Affiliations
From Policy Analysis Inc, Brookline, Mass (Messrs Huse and Lacey and Drs Oster and Killen); and the Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Mass (Dr Colditz).

Footnotes
Reprint requests to Policy Analysis Inc, 1577 Beacon St, Brookline, MA 02146 (Dr Oster).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT  

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT  

Emerging Epidemic: Diabetes in Older Adults: Demography, Economic Impact, and Pathophysiology
Gambert and Pinkstaff
Diabetes Spectr. 2006;19:221-228.
ABSTRACT | FULL TEXT  

Cost of ambulatory care of diabetes mellitus: a study from north India
Grover et al.
Postgrad. Med. J. 2005;81:391-395.
ABSTRACT | FULL TEXT  

Cooling the Foot to Prevent Diabetic Foot Wounds: A Proof-of-Concept Trial
Armstrong et al.
J. Am. Podiatr. Med. Assoc. 2005;95:103-107.
ABSTRACT | FULL TEXT  

Meta-Analysis of the Effect of Diabetes on Restenosis Rates Among Patients Receiving Coronary Angioplasty Stenting
Gilbert et al.
Diabetes Care 2004;27:990-994.
ABSTRACT | FULL TEXT  

Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries: The Mexican case
Arredondo and Zuniga
Diabetes Care 2004;27:104-109.
ABSTRACT | FULL TEXT  

The Direct Medical Cost of Type 2 Diabetes
Brandle et al.
Diabetes Care 2003;26:2300-2304.
ABSTRACT | FULL TEXT  

The cost of major comorbidity in people with diabetes mellitus
Simpson et al.
CMAJ 2003;168:1661-1667.
ABSTRACT | FULL TEXT  

Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
Petersen et al.
Science 2003;300:1140-1142.
ABSTRACT | FULL TEXT  

Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis
Bae et al.
Rheumatology (Oxford) 2003;42:46-53.
ABSTRACT | FULL TEXT  

Attributing Inpatient Medicare Costs to Diabetes Among the Texas Elderly
McCandless
Diabetes Care 2002;25:1958-1963.
ABSTRACT | FULL TEXT  

Diabetes in Employer-Sponsored Health Insurance
Peele et al.
Diabetes Care 2002;25:1964-1968.
ABSTRACT | FULL TEXT  

Comparison of Insulin Monotherapy and Combination Therapy With Insulin and Metformin or Insulin and Troglitazone in Type 2 Diabetes
Strowig et al.
Diabetes Care 2002;25:1691-1698.
ABSTRACT | FULL TEXT  

The Impact of Cardiovascular Disease on Medical Care Costs in Subjects With and Without Type 2 Diabetes
Nichols and Brown
Diabetes Care 2002;25:482-486.
ABSTRACT | FULL TEXT  

Managing care of type 2 diabetes. Learnings from T2ARDIS
Bottomley and T2ARDIS Steering Committee and UK Centres
British Journal of Diabetes & Vascular Disease 2001;1:68-72.
ABSTRACT  

Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic
Perkins et al.
Diabetes Care 2001;24:250-256.
ABSTRACT | FULL TEXT  

Screening for diabetes in pregnancy
Virjee et al.
JRSM 2001;94:502-509.
FULL TEXT  

Long-Term Disease Management Needs of Southern African Americans With Diabetes
Anderson-Loftin and Moneyham
The Diabetes Educator 2000;26:821-832.
ABSTRACT  

Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients
Elliott et al.
Arch Intern Med 2000;160:1277-1283.
ABSTRACT | FULL TEXT  

Lifetime Health and Economic Consequences of Obesity
Thompson et al.
Arch Intern Med 1999;159:2177-2183.
ABSTRACT | FULL TEXT  

Gender and the capacity of women with NIDDM to implement medical advice
Hepworth
Scand J Public Health 1999;27:260-266.
ABSTRACT  

The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Brown et al.
Arch Intern Med 1999;159:1873-1880.
ABSTRACT | FULL TEXT  

Factors Associated With Implementation of Preventive Care Measures in Patients With Diabetes Mellitus
Streja and Rabkin
Arch Intern Med 1999;159:294-302.
ABSTRACT | FULL TEXT